Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

mRNA Vaccines – A Novel Weapon Against Coronavirus

New Technology Attracts Attention

Ribonucleic acid

Related Content

Interview: BioNTech And Pfizer Explore mRNA Flu Vaccines In $120m+ Deal

Aug 16 2018

Pfizer, Fosun Partner BioNTech On mRNA COVID-19 Vaccine

Mar 17 2020

CureVac Denies Takeover Reports As It Slates Phase I Coronavirus Vaccine Study For Early Summer

Mar 18 2020

Related Companies

Sanofi

Johnson & Johnson

Johnson & Johnson

GSK plc

Clover Corp. Ltd.

CureVac NV

Moderna, Inc.

BioNTech SE

Pfizer Inc.

Merck & Co., Inc.

Boehringer Ingelheim GmbH

Eli Lilly and Company

Additional Topics

Companies Coronavirus COVID-19 Research & Development Infectious Diseases BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window